5th International Cannabinoid-Derived Pharmaceuticals Summit
Event summary
The 5th International Cannabinoid-Derived Pharmaceuticals Summit is uniting drug developers from around the globe – working to progress the field of cannabinoids. The summit remains the largest conference dedicated solely to the development of CDPs for pain, psychiatric disorders and more. This year's program will be focusing on demystifying FDA/EMA approval pathways, clinical trial design and commercialization, target biology and pharmacology, GMP-compliant product formulation, drug delivery and managing the changing regulatory environment. Cooley lawyers Marcelo Pomeranz and Daniel Knauss will speak at this event on how companies can prepare for diligence.
Featured agenda item
Getting Your House in Order – Preparing for IP Diligence
Thursday, September 8, 2022: 3:00 pm ET
Cooley lawyers Marcelo Pomeranz and Daniel Knauss are leading this session.
For more information, please email Seema Desai.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.